Log Out
 

Multiple sclerosis (MS) is typically diagnosed in women during childbearing age and is twice more frequent in females than in males, therefore, women with MS may face several pregnancy-related issues, including concerns regarding the effects of medications commonly used in MS treatment [Ghezzi et al, 2013]. Choosing the right approach to treatment during pregnancy is consequently a key consideration for women with MS.

Most disease-modifying therapies (DMTs) are contraindicated during pregnancy and most women are advised to stop using them when planning for, and during a pregnancy, unless the balance between benefit and risk favours treatment continuation. However, in the case of a severe relapse during pregnancy, female patients could be treated with a short, high dose of a corticosteroid such as methylprednisolone to speed up recovery, although this should generally be limited to disabling relapses [Miller et al, 2014].

Related Articles